The Nifty Pharma index was trading 0.25% lower at 22,389.10 during today’s session, as losses in Cipla, Biocon, and Aurobindo Pharma weighed on the sector, despite gains in Abbott India and Ajanta Pharma.
Key Movers:
- Abbott India: Up 1.27% at ₹28,803.25
- Ajanta Pharma: Up 1.45% at ₹3,010.60
- Alkem Labs: Up 0.64% at ₹5,673.45
- Cipla: Down 1.48% at ₹1,511.25
- Biocon: Down 0.23% at ₹373.00
- Divis Labs: Slight gain of 0.47% at ₹6,239.90
The global glaucoma market is projected to exceed ₹100,000 crore (approx. $12 billion) by 2030, supported by advancements in treatment modalities such as eye drops, laser therapy, and surgical interventions. The surge in healthcare investments and diagnosis rates further bolster this growth.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
